- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04817878
Cohort Construction for Preterm Infants With Growth Retardation and Its Influencing Factors
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Preterm infants are at high risk of stunting due to premature birth, insufficient intrauterine nutrient reserves, burden of various diseases after birth, and persistent nutrient liabilities. The growth retardation of premature infants at different developmental stages has an important impact on both short-term survival and long-term health. The growth and development data of premature infants during hospitalization and after discharge are very limited in foreign countries. Domestic researches on growth retardation of preterm infants only involve retrospective cross-sectional studies during hospitalization, and lack of prospective follow-up study data on growth and development data of premature infants during hospitalization and after discharge.
In this cohort, prospective clinical cohort study was used to establish a follow-up cohort of preterm infants with different gestational ages. The regular monitoring indexes of physical development and neuropsychological development of preterm infants from birth to 3 years after birth were collected. The influencing factors of preterm infants' development at different stages were recorded, and the high-risk factors leading to different stages of preterm infants' growth retardation were analyzed. In order to provide a strong scientific basis for the development evaluation and intervention of premature infants in China, a systematic and scientific clinical cohort study method was explored to improve the overall medical quality and medical level of the Department and further promote the development of the discipline.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: chunling huang, Ph.D.
- Phone Number: +86 13811485908
- Email: huangchunling_19@163.com
Study Locations
-
-
Beijing
-
Peking, Beijing, China, 100191
- Recruiting
- Peking University Third Hospital
-
Contact:
- chunling huang, Ph.D.
- Phone Number: +86 13811485908
- Email: huangchunling_19@163.con
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- All preterm infants born less than 37 weeks during the study period
Exclusion Criteria:
- Congenital malformations or genetic diseases Various surgical treatments during the newborn period Interrupted treatment or discharged automatically
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Late preterm infant group
Gestational age 33 weeks-36 weeks
|
Physical development assessment (head circumference, length, weight), Neurodevelopment assessment at 36 to 40 weeks of correction (GMS assessment, NBNA assessment), neurodevelopment assessment at 18 months, 24 months, and 36 months (ASQ scale, Language assessment, Wei-style scale), audiovisual screening, etc.
|
|
Very premature infant group
Gestational age 28 weeks-32 weeks
|
Physical development assessment (head circumference, length, weight), Neurodevelopment assessment at 36 to 40 weeks of correction (GMS assessment, NBNA assessment), neurodevelopment assessment at 18 months, 24 months, and 36 months (ASQ scale, Language assessment, Wei-style scale), audiovisual screening, etc.
|
|
Super preterm infant group
Gestational age less than 28 weeks
|
Physical development assessment (head circumference, length, weight), Neurodevelopment assessment at 36 to 40 weeks of correction (GMS assessment, NBNA assessment), neurodevelopment assessment at 18 months, 24 months, and 36 months (ASQ scale, Language assessment, Wei-style scale), audiovisual screening, etc.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Assessment of extrauterine growth retardation of preterm infants at 36-40 weeks of gestational age correction
Time Frame: correct gestational age 36~40 weeks
|
According to Fenton 2003 growth curve of premature infants, the weight, length, and head circumference of preterm infants with corrected gestational age of 36-40 weeks were evaluated, If the weight, length and head circumference are lower than the 10th percentile of the corresponding gestational age, the child is diagnosed as EUGR(extrauterine growth retardation)
|
correct gestational age 36~40 weeks
|
|
Assessment of neurodevelopmental retardation of preterm infants at 36-40 weeks of gestational age correction
Time Frame: correct gestational age 36~40 weeks
|
IF the NBNA score of preterm infants at 36-40 weeks of correction is lower than 36, and the abnormal GMs is evaluated, the child is diagnosed as neurodevelopmental retardation.
|
correct gestational age 36~40 weeks
|
|
Assessment of low weight of preterm infants at 2 to 3 years of age
Time Frame: 2~3 years old
|
Compared with the same age and gender reference population standard, children's weight below the median minus 2 standard deviations (i.e. less than the 3rd percentile) is diagnosed as low weight
|
2~3 years old
|
|
Assessment of growth retardation of preterm infants at 2 to 3 years of age
Time Frame: 2~3 years old
|
Compared with the same age and gender reference population standard, children's height below the median minus 2 standard deviations (i.e. less than the 3rd percentile) is diagnosed as growth retardation
|
2~3 years old
|
|
Assessment of small head circumference of preterm infants at 2 to 3 years of age
Time Frame: 2~3 years old
|
Compared with the same age and gender reference population standard, the children's occipitofrontal circumference (OFC) less than 2 standard deviations (SD) of the mean OFC (i.e. less than the 3rd percentile) is diagnosed as small head circumference
|
2~3 years old
|
|
Assessment of neurodevelopmental retardation of preterm infants at 2 to 3 years of age
Time Frame: 2~3 years old
|
IF the Wechsler intelligence scales score is lower than 70, the child is diagnosed as neurodevelopmental retardation.
|
2~3 years old
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: xiaomei tong, Ph.D., Peking University Third Hospital
- Study Director: yanmei chang, Ph.D., Peking University Third Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- bysy2020-423-01
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Problem With Growth of an Infant
-
Hacettepe UniversityThe Scientific and Technological Research Council of TurkeyCompletedProblem With Growth of an Infant
-
University of NebraskaAlegent Health Bergan Mercy Medical CenterCompletedProblem With Growth of an InfantUnited States
-
Yonsei UniversityNot yet recruitingNeoplasms of Connective and Soft Tissue With an Unspecified Anatomical Site
-
Arkansas Children's Hospital Research InstituteCompletedInterface Acceptance During Delivery of Aerosol Medicine to an Infant or ChildUnited States
-
Arizona State UniversityRecruitingGut Microbiome | Infant Growth | Neurocognitive Correlates of Eating HabitsUnited States
-
Anqing Municipal HospitalRecruitingSore Throat | Tracheal Tubes With an Inner Diameter of 6.0mm | Tracheal Tubes With an Inner Diameter of 6.5mm | Tracheal Tubes With an Inner Diameter of 7.0mmChina
-
University of Sao PauloCompletedTo Study the Influence of an Multifocal Intraocular Lens With Different Addition on Intermediate Visual AcuityBrazil
-
Assistance Publique - Hôpitaux de ParisCompletedPatients With Advanced Lymphoid Malignancies in the Absence of an HLA Identical or Mismatch DonorFrance
-
Rutgers, The State University of New JerseyMonell Chemical Senses CenterCompletedTreatment of Sweet Taste Receptors Without or With an Oral Rinse of Ibuprofen Solution in Healthy Participants | Treatment of Sweet Taste Receptors Without or With an Oral Rinse of Naproxen Solution in Healthy ParticipantsUnited States
-
Nobel BiocareUnknownHealthy Volunteers With Severely Resorbed Jaws in Need of an Implant Supported RestorationGermany
Clinical Trials on Developmental assessment
-
Bartosz M. RadtkeRecruitingChild Development | Infant Development | Early Childhood DevelopmentPoland
-
Eunice Kennedy Shriver National Institute of Child...Completed
-
University of AarhusNovo Nordisk A/S; Aarhus University HospitalCompleted
-
University Hospital, ToulouseNot yet recruiting
-
Zeynep HOŞBAYCompletedSpinal Muscular Atrophy Type ITurkey
-
Boston Children's HospitalRecruitingInfant Development | Development Delay | CardiologyUnited States
-
National Taiwan University HospitalUnknown
-
Assistance Publique - Hôpitaux de ParisURC-CIC Paris Descartes Necker Cochin; Ville Evrard HospitalActive, not recruitingAutism Spectrum DisordersFrance
-
Children's Hospital of Fudan UniversityRecruiting
-
University of FloridaAmerican Heart AssociationCompleted